Gonorrhea is a sexually transmitted infection (STI) caused by the bacterium Neisseria gonorrhoeae. It is one of the most common STIs, affecting millions of individuals worldwide annually. Gonorrhea primarily infects the mucous membranes of the reproductive tract, including the cervix, uterus, and fallopian tubes in women, and the urethra in both men and women. It can also affect the mouth, throat, eyes, and rectum.
The transmission of gonorrhea typically occurs during vaginal, anal, or oral sex with an infected partner. A significant concern with gonorrhea is its capacity to be asymptomatic, particularly in women. When symptoms are present, they can vary. In men, common symptoms include a burning sensation during urination and a white, yellow, or green discharge from the penis. Women may experience increased vaginal discharge, painful urination, vaginal bleeding between periods, and abdominal or pelvic pain. If left untreated, gonorrhea can lead to serious health complications. In women, it can cause pelvic inflammatory disease (PID), which can result in infertility, ectopic pregnancy, and chronic pelvic pain. In men, gonorrhea can lead to painful inflammation of the ducts in the testicles, which can also result in infertility.
One of the most concerning aspects of gonorrhea is its growing resistance to antibiotics. Over the years, Neisseria gonorrhoeae has developed resistance to many of the antibiotics used for treatment, making it increasingly difficult to treat. Currently, the recommended treatment involves a combination of two antibiotics: ceftriaxone and azithromycin. However, the emergence of antibiotic-resistant strains of gonorrhea is a significant public health concern, emphasizing the need for new treatment strategies.
Prevention of gonorrhea is primarily through safe sex practices, including the use of condoms. Regular screening for sexually active individuals, particularly those with new or multiple sexual partners, is crucial for early detection and treatment. Public health campaigns also focus on education about STIs, promoting safe sex practices, and encouraging regular health check-ups to prevent the spread of gonorrhea and other STIs.
What is NAAT?
Detection of gonorrhea in STD panels is frequently achieved using Nucleic Acid Amplification Tests (NAATs) conducted on urine samples. NAATs have emerged as the preferred method for gonorrhea testing due to their superior sensitivity and specificity compared to culture or other diagnostic methods. These molecular tests amplify genetic material from Neisseria gonorrhoeae, allowing for the detection of the bacterium even in low quantities. The use of urine samples for this purpose offers a non-invasive, patient-friendly testing option. This is particularly advantageous for large-scale screening programs and in settings where patient compliance is critical. A key benefit of urine-based NAATs is the ability to simultaneously test for both gonorrhea and Chlamydia trachomatis, streamlining the testing process and facilitating early detection of these infections. Early and accurate detection of gonorrhea is crucial for effective treatment, typically with antibiotics, and for preventing serious health complications such as pelvic inflammatory disease in women and epididymitis in men. Furthermore, timely identification and treatment of gonorrhea are vital for preventing its spread, as many infections are asymptomatic and can unknowingly be transmitted. The high efficacy of NAATs in detecting gonorrhea in urine samples plays a crucial role in the management and control of this STD, highlighting the importance of these tests in contemporary sexual health care and public health initiatives.
Gonorrhea, NAAT, Urine
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.